Clinical Trial

A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss

Name: A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Weight Loss — clinical trial record (NCT07663630)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Study to investigate the effect of ponsegromab on skeletal muscle mass and physical function in adult participants with non-small cell lung cancer associated cachexia.

Trial Details

NCT Number	NCT07663630
Lead Sponsor	Pfizer
Conditions	Non-small Cell Lung Cancer (NSCLC), Cachexia
Enrollment	80 participants
Start Date	2026-07-22
Primary Completion	2028-02-02 (estimated)
Study Completion	2029-03-29 (estimated)
Updated on ClinicalTrials.gov	2026-06-23